Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Fundraising

Bowery Farming

Bowery Farming Raises $150M in Series C

151 W 26th Street, New York, NY 10001August 20, 20242 min read
Employees
200+

Bowery Farming Raises $150M in Series C


Bowery Farming has successfully raised $150M in a Series C at a $647M valuation led by Fidelity, GV, General Catalyst, Temasek Holdings, GGV Capital.


Company Overview


Bowery Farming is a AgriTech company headquartered in 151 W 26th Street, New York, NY 10001, founded in 2015 with 200+ employees.


Indoor vertical farming


Fundraising Details


  • Amount Raised: $150M
  • Round Type: Series C
  • Valuation: $647M
  • Date: 2024-08-20
  • Investors: Fidelity, GV, General Catalyst, Temasek Holdings, GGV Capital

About Bowery Farming


Indoor vertical farming The company is positioned in the AgriTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 151 W 26th Street, New York, NY 10001
  • Founded: 2015
  • Team Size: 200+
  • Industry: AgriTech

What This Means


This funding round demonstrates strong investor confidence in Bowery Farming's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AgriTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Bowery Farming's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $647M valuation marks an important milestone for Bowery Farming, positioning the company among notable players in the AgriTech industry.


Looking Ahead


With this new capital, Bowery Farming is well-positioned to execute on its growth strategy and continue building innovative solutions in the AgriTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-08-20. For more information about Bowery Farming, visit their headquarters at 151 W 26th Street, New York, NY 10001.

Company Info

Headquarters
151 W 26th Street, New York, NY 10001
Founded
2015
Team Size
200+

Topics

Fundraising(2912)Series C(300)AgriTechBowery Farming

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min readβ€’$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free